e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 28, 2004

Targeted Genetics Corporation


(Exact name of registrant as specified in charter)
         
Washington   0-23930   91-1549568

 
 
 
 
 
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
1100 Olive Way, Suite 100, Seattle, Washington   98101

 
 
 
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (206) 623-7612

Not Applicable


(Former name or former address, if changed since last report)

1


TABLE OF CONTENTS

Item 7. Exhibits.
Item 12. Results and Operations of Financial Condition.
SIGNATURES
EXHIBIT 99.1


Table of Contents

Item 7. Exhibits.

(a)   Financial statements of business acquired.
 
    Not applicable.
 
(b)   Pro forma financial information.
 
    Not applicable.
 
(c)   Exhibits.
     
Exhibit    
No.
  Description
99.1
  Press Release of Targeted Genetics Corporation dated April 28, 2004

Item 12. Results and Operations of Financial Condition.

     On April 28, 2004, Targeted Genetics Corporation issued a press release announcing its financial results for the quarter ended March 31, 2004. A copy of the press release is furnished as Exhibit 99.1 and is incorporated into this current report by reference.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

             
    TARGETED GENETICS CORPORATION
 
           
  By:   /s/ Todd E. Simpson
Todd E. Simpson
   
      Vice President, Finance and Administration and    
      Chief Financial Officer, Secretary and Treasurer    
 
      (Principal Financial and Accounting Officer)    
Date: April 28, 2004

 


Table of Contents

EXHIBIT INDEX

     
Exhibit    
No.
  Description
99.1
  Press Release of Targeted Genetics Corporation dated April 28, 2004